Pulmonary fibrosis, unspecified
ICD-10 J84.10 is a billable code used to indicate a diagnosis of pulmonary fibrosis, unspecified.
Pulmonary fibrosis, unspecified, refers to a group of lung diseases that result in scarring (fibrosis) of the lungs, leading to progressive respiratory impairment. Clinically, patients may present with symptoms such as dyspnea (shortness of breath), chronic cough, and fatigue. The disease primarily affects the interstitial tissue of the lungs, which is crucial for gas exchange. As the fibrosis progresses, lung compliance decreases, resulting in reduced oxygenation and respiratory failure in advanced stages. Diagnosis typically involves a combination of clinical evaluation, imaging studies such as high-resolution computed tomography (HRCT), and pulmonary function tests to assess lung capacity and function. A definitive diagnosis may require a lung biopsy to rule out other interstitial lung diseases. The progression of pulmonary fibrosis can vary significantly among individuals, with some experiencing rapid deterioration while others may have a more indolent course. Early detection and management are essential to improve quality of life and slow disease progression.
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
J84.10 covers unspecified pulmonary fibrosis, which may include various forms of interstitial lung disease that lead to lung scarring without a specific etiology identified. It does not include specific types like idiopathic pulmonary fibrosis (J84.11) or those due to known causes.
J84.10 should be used when the specific type of pulmonary fibrosis is not determined or documented. If a more specific diagnosis is available, such as idiopathic pulmonary fibrosis or fibrosis due to a known cause, those codes should be utilized.
Documentation should include a comprehensive clinical evaluation, imaging studies (preferably HRCT), pulmonary function tests, and any relevant laboratory results. A detailed history of symptoms and potential exposures should also be included.
